Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: Potential implications for Parkinson's disease

Biochemical and Biophysical Research Communications

Volumn 222, Issue 2, 1996, Pages 607-611

  Soto Otero, Ramón ^a   Riguera Vega, Ricardo ^a   Méndez Álvarez, Estefanía ^a   Sánchez Sellero, Inés ^a   Lamas, Manuel López Rivadulla ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; TETRAHYDROISOQUINOLINE; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIGARETTE SMOKING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SMOKING; TOBACCO;

ANIMALIA; NICOTIANA TABACUM;

EID: 0030585329     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.0791     Document Type: Article

References (24)

1. 1. Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, Y. (1983) Science 219, 979-980.
2. 2. Heikkila, R. E., Hess, A., and Duvoison, R. C. (1984) Science 224, 1451-1453.
3. 3. Niwa, T., Yoshizumi, H., Kaneda, N., Hashizume, Y., and Nagatzu, T. (1987) Biochem. Biophys. Res. Commun. 144, 1084-1089.
4. 4. Nagatsu, T., and Yoshida, M. (1988) Neurosci. Lett. 87, 178-182.
5. 5. Kohno, M., Ohta, S., and Hirobe, M. (1986) Biochem. Biophys. Res. Commun. 140, 448-454.
6. 6. Niwa, T., Yoshizumi, H., Tatematsu, A., Matsuura, S., and Nagatsu, T. (1989) J. Chromatogr. 493, 347-352.
7. 7. Niwa, T., Takeda, N., Tatematsu, A., Matsuura, S., Yoshida, M., and Nagatsu, T. (1988) J. Chromatogr. 452, 85-91.
8. 8. Naoi, M., Matsuura, S., Takahashi, T., and Nagatsu, T. (1989) Biochem. Biophys. Res. Commun. 161, 1231-1239.
9. 9. Nefzger, M. D., Quadfasel, F. A., and Karl, V. C. (1968) Am. J. Epidemiol. 88, 149-158.
10. 10. Kessler, I. I., and Diamond, E. C. (1971) Am. J. Epidemiol. 94, 16-25.
11. 11. Baron, J. A. (1986) Neurology 36, 1490-1496.
12. 12. Carr, L. A., and Basham, J. K. (1991) Life Sci. 48, 1173-1177.
13. 13. Gresham, L. S., Molgaard, C. A., and Smith, R. A. (1993) Neuroepidemiology 12, 114-116.
14. 14. Clemens, P., Baron, J. A., Coffey, D., and Reeves, A. (1995) Psychopharmocology 117, 253-256.
15. 15. Yu, P. H., and Boulton, A. A. (1987) Life Sci. 41, 675-682.
16. 16. Yu, P. H., Durden, D. A., Davis, B. A., and Boulton, A. A. (1988) Biochem. Pharmacol. 37, 3729-3734.
17. 17. Winstead, M. B., Ciccarelli, C. A., and Winchell, H. S. (1978) J. Pharmacol. Exp. Ther. 205, 751-756.
18. 18. Beaumont, D., Waigh, R. D., Sunbhanich, M., and Nott, M. W. (1983) J. Med. Chem. 26, 507-515.
19. 19. Miyake, T., and Shibamoto, T. (1995) J. Chromatogr. A 693, 376-381.
20. 20. Sakuma, H., Kusama, M., Yamaguchi, K., Matsuki, T., and Sugawara, S. (1984) Beitr. Tabakforsh. Int. 12, 199-209.
21. 21. Way, J. L. (1984) Annu. Rev. Pharmacol. Toxicol. 24, 451-481.
22. 22. Heap, L., Ward, R. J., Abiaka, C., Dexter, D., Lawlor, M., Pratt, O., Thomson, A., Shaw, K., and Peters, T. J. (1995) Biochem. Pharmacol. 50, 263-270.
23. 23. Grandinetti, A., Morens, D. M., Reed, D., and MacEachern, D. (1994) Am. J. Epidemiol. 139, 1129-1138.
24. 24. Hubble, J. P., Cao, T., Hassanein, R. E. S., Neuberger, J. S., and Koller, W. C. (1993) Neurology 43, 1693-1697.